-
-
Finance -
Pharma & Human Health -
Editor's Choice -
Pharma & Human Health
Editor’s Choice
Editor's Choice
Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
The majority of the gut microbiota is unculturable using standard laboratory techniques, which has been well-documented since the advent of next generation sequencing in microbiome research. This limitation makes it difficult to characterise the phenotype […]
Editor's Choice
Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
With bacterial strains of the same species exhibiting remarkably different characteristics, it is vital biotic developers accurately characterise what strains are present in their product. This enables developers to maximise the biotics’ therapeutic potential, provide […]
Editor's Choice
Scientists decode diet from stool DNA – no questions asked
Scientists have developed a breakthrough method to track diet using stool metagenomic data. Developed by researchers at the Institute for Systems Biology (ISB), the new method, called MEDI (Metagenomic Estimation of Dietary Intake), detects food-derived […]
In Case you Missed it:
Finance
BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million
BiomX Inc. (NYSE American: PHGE, the “Company” or “BiomX”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it has entered into a securities purchase agreement […]
Editor's Choice
Scientists decode diet from stool DNA – no questions asked
Scientists have developed a breakthrough method to track diet using stool metagenomic data. Developed by researchers at the Institute for Systems Biology (ISB), the new method, called MEDI (Metagenomic Estimation of Dietary Intake), detects food-derived […]
Editor's Choice
Hervé Affagard talks Phase 3 results, the regulatory landscape and industry collaborations
In early January MaaT Pharma made waves in the pharma world with the announcement of positive topline results for their phase 3 trial of MaaT013 in acute Graft-versus-Host Disease. With robust efficacy and safety data, […]
Pharma & Human Health
Global “sisterhood” seeks to understand what makes a healthy vaginal microbiome
Vaginas host a complex microcosm of bacteria and yeasts that can fluctuate over time. However, little is known about these microbial communities and their roles in a person’s health, and 9 out of 10 studies […]
Pharma & Human Health
Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine
Vedanta Biosciences today announced the publication of additional results from the Phase 2 CONSORTIUM study for its lead candidate, VE303, which is being evaluated for prevention of recurrent Clostridioides difficile infection (rCDI). The new analyses were published […]
Pharma & Human Health
Changes in microbiome predict risk for sexually transmitted disease
Women who develop bacterial vaginosis (BV) often later acquire chlamydia, a common and potentially serious sexually transmitted bacterial infection. Now, researchers at Albert Einstein College of Medicine, Roswell Park Comprehensive Cancer Center, and the Icahn School of Medicine at Mount […]
Finance
Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced a first closing of $27 million (circa £22 million) in its Series E financing round. The […]
Animal Health
Penn Medicine launches a pioneering project to study the human virome puzzle
For over a decade, scientists have studied the microbiome, the environment of microorganisms that live on and in the body, and how it affects health and disease. Much less is known about a part of […]
